Hims & Hers Health, Inc. (HIMS)
| Market Cap | 3.01B |
| Revenue (ttm) | 959.40M |
| Net Income (ttm) | -2.35M |
| Shares Out | 206.41M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | 102.03 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,570,411 |
| Open | 14.12 |
| Previous Close | 14.04 |
| Day's Range | 14.00 - 14.67 |
| 52-Week Range | 5.65 - 17.16 |
| Beta | 0.96 |
| Analysts | Buy |
| Price Target | 14.25 (-2.2%) |
| Earnings Date | May 6, 2024 |
About HIMS
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supp... [Read more]
Financial Performance
In 2023, HIMS's revenue was $872.00 million, an increase of 65.49% compared to the previous year's $526.92 million. Losses were -$23.55 million, -64.15% less than in 2022.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for HIMS stock is "Buy." The 12-month stock price forecast is $14.25, which is a decrease of -2.20% from the latest price.
News
Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Anja Manuel to the company's Board of...
3-Stock Lunch: PLTR, HIMS & GPS
Courtney Garcia, Payne Capital Management senior wealth advisor, to discuss investment plays for three stocks including; Palantir, Hims and Hers Health Inc. and Gap.
Him & Hers earnings beat estimates, CEO weighs in on campus protests
CNBC's Andrew Ross Sorkin reports on the latest news.
Hims & Hers shares rally as forecast bumped higher and more profitability said to be ahead
Shares of Hims & Hers Health Inc. rose after hours on Monday after the online wellness platform bumped its full-year sales forecast higher, following sharp increases in subscribers and profits during ...
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter...
Hims & Hers CEO walks back praise for anti-Israel protesters after stock drops
Hims & Hers founder and CEO Andrew Dudum said Sunday that his earlier comments praising anti-Israel protesters on college campuses were "misconstrued by some."
Hims & Hers stock slides after CEO's praise for anti-Israel protesters
Hims & Hers Health stock declined Friday by about 8% after CEO Andrew Dudum's praise for anti-Israel campus protesters in a social media post last week.
Exowatt Launches with $20 Million to Modernize Data Center Power for the AI Era
MIAMI--(BUSINESS WIRE)--Exowatt, a next-generation renewable energy company, today unveiled a first-of-its-kind modular energy platform designed to power energy-intensive data centers along with a $20...
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers," NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2024 financial results...
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Christopher Payne to the company's Bo...
LYFT, CCJ, HIMS: Market Trends to Watch
The two main themes of the year are still playing out: artificial intelligence and Ozempic, notes Luke Lloyd. He discusses market trends to watch, as well as investment strategies to consider.
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that members of the company's management team will be pa...
Hims & Hers soars 32% on rapid growth in mental health, weight loss and dermatology treatments
Shares of Shares of Hims & Hers Health popped Tuesday after the company reported better-than-expected quarterly results.
Hims & Hers (HIMS) Hits 52-Week High After Earnings
Hims & Hers (HIMS) soars after earnings. Renita Young discuss this as Hims & Hers hit a new 52-week high after earnings.
Hims & Hers' stock jumps on hopes of first profitable year, as it floats opportunities in weight loss
Shares of Hims & Hers Health Inc. rallied after hours on Monday, after the online wellness platform said 2024 would be its first year of positive net income and forecast first-quarter and full-year sa...
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth quart...
Hims & Hers Names Dan Kenger as the Company's First Chief Design Officer
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Dan Kenger will join the company's executive team as the...
Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2023 fi...
Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care
SAN FRANCISCO & HARTFORD, Conn.--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, and Connecticut's most transformative health system, H...
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today unveiled Weight Loss by Hims & Hers, a comprehensive and customiza...
Hims and Hers narrows loss, raises revenue guidance for the year
Shares of Hims & Hers Health Inc. HIMS, -3.09% rose more than 3% in the extended session Monday after the telehealth company narrowed its quarterly loss and raised its sales guidance for the year, say...
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today reported financial results for the third quarter ...
Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company,” NYSE: HIMS), the leading health and wellness platform, today announced that its Board of Directors has authori...
Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS), the leading health and wellness platform, today introduced MedMatch, a technology designed to tr...
Hims & Hers Names Khobi Brooklyn As Chief Communications Officer
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced communications veteran Khobi Brooklyn will further posit...